CK2 Molecular Targeting—Tumor Cell-Specific Delivery of RNAi in Various Models of Cancer

Pharmaceuticals - Switzerland
doi 10.3390/ph10010025
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Mechanism and Efficacy of Sub-50-Nm Tenfibgen Nanocapsules for Cancer Cell-Directed Delivery of Anti-Ck2 RNAi to Primary and Metastatic Squamous Cell Carcinoma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2014English

Tumor-Specific Targeting of Pancreatic Cancer With Shiga Toxin B-Subunit

Molecular Cancer Therapeutics
Cancer ResearchOncology
2011English

Targeting Liposomal Chemotherapy via Both Tumor Cell-Specific and Tumor Vasculature-Specific Ligands Potentiates Therapeutic Efficacy

Cancer Research
Cancer ResearchOncology
2006English

Characterizing the Convergence of Protein Kinase CK2 and Caspase-3 Reveals Isoform-Specific Phosphorylation of Caspase-3 by CK2α′: Implications for Pathological Roles of CK2 in Promoting Cancer Cell Survival.

Oncotarget
Oncology
2013English

Mucosal Delivery of RNAi Therapeutics

RNA Interference from Biology to Therapeutics
2012English

Tumor Endothelial Cell-Specific Drug Delivery System Using Apelin-Conjugated Liposomes

PLoS ONE
Multidisciplinary
2013English

Antibody Targeting GRP78 Enhances the Efficacy of Radiation Therapy in Human Glioblastoma and Non–Small Cell Lung Cancer Cell Lines and Tumor Models

Clinical Cancer Research
Cancer ResearchOncology
2016English

Tumor-Specific Genetic Aberrations in Cell-Free DNA of Gastroesophageal Cancer Patients

Journal of Gastroenterology
Gastroenterology
2018English

Applications of Cell-Penetrating Peptides for Tumor Targeting and Future Cancer Therapies

Pharmaceuticals
Molecular MedicinePharmaceutical Science
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy